Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00209859
Status:
COMPLETED
Last Update Posted:
2005-09-21
First Post:
2005-09-16
Brief Title:
Methotrexate and Cyclosporine in Treatment of Early Rheumatoid Arthritis
Sponsor:
Hvidovre University Hospital
Organization:
Hvidovre University Hospital
Study Overview
Official Title:
Combination Treatment With Methotrexate and Cyclosporine in Early Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate whether cyclosporine added to methotrexate and steroid increases the possibility of inflammatory management early in the disease furthermore to investigate the possible steroid-sparing effect of cyclosporine in patients with recently diagnosed rheumatoid arthritis
Detailed Description:
Design Multicentre prospective randomised double-blind study with parallel design
Selection of patients Patients with recently diagnosed rheumatoid arthritis less than 6 months of persistent synovitis
Selection of patients Patients with recently diagnosed rheumatoid arthritis less than 6 months of persistent synovitis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None